These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35041837)

  • 1. Liraglutide, a glucagon-like peptide-1 receptor agonist, induces ADAM10-dependent ectodomain shedding of RAGE via AMPK activation in human aortic endothelial cells.
    Baek CH; Kim H; Moon SY; Yang WS
    Life Sci; 2022 Mar; 292():120331. PubMed ID: 35041837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPK boosts ADAM10 shedding activity in human aortic endothelial cells by promoting Rab14-dependent ADAM10 cell surface translocation.
    Baek CH; Kim H; Moon SY; Yang WS
    Biochem Biophys Res Commun; 2023 Oct; 675():54-60. PubMed ID: 37451218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25-Dihydroxyvitamin D3 Attenuates the Effects of Lipopolysaccharide by Causing ADAM10-Dependent Ectodomain Shedding of Toll-Like Receptor 4.
    Yang WS; Kim JJ; Han NJ; Lee EK; Park SK
    Cell Physiol Biochem; 2017; 41(5):2104-2116. PubMed ID: 28427048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diosgenin, an Activator of 1,25D3-MARRS Receptor/ERp57, Attenuates the Effects of TNF-α by Causing ADAM10-Dependent Ectodomain Shedding of TNF Receptor 1.
    Yang WS; Moon SY; Lee MJ; Lee EK; Park SK
    Cell Physiol Biochem; 2017; 43(6):2434-2445. PubMed ID: 29073626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigallocatechin-3-gallate downregulates lipopolysaccharide signaling in human aortic endothelial cells by inducing ectodomain shedding of TLR4.
    Baek CH; Kim H; Moon SY; Park SK; Yang WS
    Eur J Pharmacol; 2019 Nov; 863():172692. PubMed ID: 31557474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginine vasopressin attenuates the effects of TNF-α in aortic endothelial cells by inducing ectodomain shedding of TNF receptor 1.
    Yang WS; Moon SY; Han NJ; Lee MJ; Park SK
    Biochem Biophys Res Commun; 2019 Apr; 511(4):780-786. PubMed ID: 30833075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectodomain Shedding of RAGE and TLR4 as a Negative Feedback Regulation in High-Mobility Group Box 1-Activated Aortic Endothelial Cells.
    Yang WS; Kim JJ; Lee MJ; Lee EK; Park SK
    Cell Physiol Biochem; 2018; 51(4):1632-1644. PubMed ID: 30497069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liraglutide improved the cognitive function of diabetic mice via the receptor of advanced glycation end products down-regulation.
    Zhang H; Chu Y; Zheng H; Wang J; Song B; Sun Y
    Aging (Albany NY); 2020 Nov; 13(1):525-536. PubMed ID: 33298623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide-1 analogue liraglutide ameliorates atherogenesis via inhibiting advanced glycation end product-induced receptor for advanced glycosylation end product expression in apolipoprotein-E deficient mice.
    Li P; Tang Z; Wang L; Feng B
    Mol Med Rep; 2017 Sep; 16(3):3421-3426. PubMed ID: 28713911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,25-dihydroxyvitamin D3 causes ADAM10-dependent ectodomain shedding of tumor necrosis factor receptor 1 in vascular smooth muscle cells.
    Yang WS; Kim HW; Lee JM; Han NJ; Lee MJ; Park SK
    Mol Pharmacol; 2015; 87(3):533-42. PubMed ID: 25556238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D-induced ectodomain shedding of TNF receptor 1 as a nongenomic action: D3 vs D2 derivatives.
    Yang WS; Yu H; Kim JJ; Lee MJ; Park SK
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):18-25. PubMed ID: 26385608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JNK and ATF4 as two important platforms for tumor necrosis factor-α-stimulated shedding of receptor for advanced glycation end products.
    Miyoshi A; Koyama S; Sasagawa-Monden M; Kadoya M; Konishi K; Shoji T; Inaba M; Yamamoto Y; Koyama H
    FASEB J; 2019 Mar; 33(3):3575-3589. PubMed ID: 30452882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liraglutide, a glucagon-like peptide-1 receptor agonist, ameliorates inflammation and apoptosis via inhibition of receptor for advanced glycation end products signaling in AGEs induced chondrocytes.
    Zhang X; Jiang J; Xu J; Chen J; Gu Y; Wu G
    BMC Musculoskelet Disord; 2024 Jul; 25(1):601. PubMed ID: 39080620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin-3-Gallate Attenuates the Effects of TNF-α in Vascular Endothelial Cells by Causing Ectodomain Shedding of TNF Receptor 1.
    Yang WS; Moon SY; Lee MJ; Park SK
    Cell Physiol Biochem; 2016; 38(5):1963-74. PubMed ID: 27161171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Receptor for Advanced Glycation End Products (RAGE) Ectodomain Shedding and Its Role in Cell Function.
    Braley A; Kwak T; Jules J; Harja E; Landgraf R; Hudson BI
    J Biol Chem; 2016 Jun; 291(23):12057-73. PubMed ID: 27022018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAM17-Mediated Ectodomain Shedding of Toll-Like Receptor 4 as a Negative Feedback Regulation in Lipopolysaccharide-Activated Aortic Endothelial Cells.
    Yang WS; Kim JJ; Lee MJ; Lee EK; Park SK
    Cell Physiol Biochem; 2018; 45(5):1851-1862. PubMed ID: 29510400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes.
    Lee AC; Lam JK; Shiu SW; Wong Y; Betteridge DJ; Tan KC
    PLoS One; 2015; 10(9):e0137330. PubMed ID: 26325204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGCG-rich green tea extract stimulates sRAGE secretion to inhibit S100A12-RAGE axis through ADAM10-mediated ectodomain shedding of extracellular RAGE in type 2 diabetes.
    Huang SM; Chang YH; Chao YC; Lin JA; Wu CH; Lai CY; Chan KC; Tseng ST; Yen GC
    Mol Nutr Food Res; 2013 Dec; 57(12):2264-8. PubMed ID: 23901023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism.
    Andreozzi F; Raciti GA; Nigro C; Mannino GC; Procopio T; Davalli AM; Beguinot F; Sesti G; Miele C; Folli F
    J Transl Med; 2016 Jul; 14(1):229. PubMed ID: 27473212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiatherogenic effects of liraglutide in hyperglycemic apolipoprotein E-null mice via AMP-activated protein kinase-independent mechanisms.
    Koshibu M; Mori Y; Saito T; Kushima H; Hiromura M; Terasaki M; Takada M; Fukui T; Hirano T
    Am J Physiol Endocrinol Metab; 2019 May; 316(5):E895-E907. PubMed ID: 30860874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.